Simon Faissner

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Myasthenia Gravis

Top Venues

Therapeutic advances in neurological disorders

Proceedings of the National Academy of Sciences of the United States of America

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Simon Faissner, Jeremias Motte, Melissa Sgodzai, Christian Geis, Aiden Haghikia, Dimitrios Mougiakakos, Dominic Borie, Roland Schroers, Ralf Gold
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences of the United States of America 121 (26) (2024)
Simon Faissner, Marielena Bongert, Paulina Trendelenburg, Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis. Therapeutic advances in neurological disorders 17 (2024)
Simon Faissner, Jeremias Motte, Melissa Sgodzai, Christian Geis, Aiden Haghikia, Dimitrios Mougiakakos, Dominic Borie, Roland Schroers, Ralf Gold
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences of the United States of America 121 (26) (2024)
Simon Faissner, Jeremias Motte, Melissa Sgodzai, Christian Geis, Aiden Haghikia, Dimitrios Mougiakakos, Dominic Borie, Roland Schroers, Ralf Gold
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences of the United States of America 121 (26) (2024)
Simon Faissner, Marielena Bongert, Paulina Trendelenburg, Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis. Therapeutic advances in neurological disorders 17 (2024)
Simon Faissner, Jeremias Motte, Melissa Sgodzai, Christian Geis, Aiden Haghikia, Dimitrios Mougiakakos, Dominic Borie, Roland Schroers, Ralf Gold
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences of the United States of America 121 (26) (2024)
Antonios Bayas, Monika Christ, Simon Faissner, Juliane Klehmet, Refik Pul, Thomas Skripuletz, Sven G Meuth
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials. Therapeutic advances in neurological disorders 16 (2023)
Antonios Bayas, Monika Christ, Simon Faissner, Juliane Klehmet, Refik Pul, Thomas Skripuletz, Sven G Meuth
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials. Therapeutic advances in neurological disorders 16 (2023)
Ümmügülsüm Koc, Steffen Haupeltshofer, Katharina Klöster, Seray Demir, Ralf Gold, Simon Faissner
Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal Encephalomyelitis. Cells 12 (4) (2023)
Ümmügülsüm Koc, Steffen Haupeltshofer, Katharina Klöster, Seray Demir, Ralf Gold, Simon Faissner
Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal Encephalomyelitis. Cells 12 (4) (2023)
Ümmügülsüm Koc, Steffen Haupeltshofer, Katharina Klöster, Seray Demir, Ralf Gold, Simon Faissner
Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal Encephalomyelitis. Cells 12 (4) (2023)
Simon Faissner, Ralf Gold
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments. CNS drugs 36 (8) (2022)
Simon Faissner, Neele Heitmann, Ricarda Rohling, Ulas Ceylan, Marielena Bongert, Carlos Plaza-Sirvent, Corinna Marheinecke, Xiomara Pedreiturria, Ilya Ayzenberg, Kerstin Hellwig, Ingo Schmitz, Stephanie Pfaender, Ralf Gold
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination. Therapeutic advances in neurological disorders 15 (2022)
Jannis Achenbach, Carsten Saft, Simon Faissner, Gisa Ellrichmann
Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort. Therapeutic advances in neurological disorders 15 (2022)
Daniel Richter, Hannah Schulze, Jeyanthan Charles James, Nadine Siems, Nadine Trampe, Ralf Gold, Christos Krogias, Simon Faissner
Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study. Journal of neurology 269 (9) (2022)
Simon Faissner, Neele Heitmann, Ricarda Rohling, Ulas Ceylan, Marielena Bongert, Carlos Plaza-Sirvent, Corinna Marheinecke, Xiomara Pedreiturria, Ilya Ayzenberg, Kerstin Hellwig, Ingo Schmitz, Stephanie Pfaender, Ralf Gold
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination. Therapeutic advances in neurological disorders 15 (2022)
Simon Faissner, Daniel Richter, Ulas Ceylan, Christiane Schneider-Gold, Ralf Gold
COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of neurology (2021)
Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, Christos Krogias, Ralf Gold
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany. Therapeutic advances in neurological disorders 14 (2021)
Simon Faissner
Letter to the editor regarding Gholamzad et al., "A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future". Inflammation research : official journal of the European Histamine Research Society ... [et al.] 69 (2) (2020)
Simon Faissner, Carolin Schwake, Michael Gotzmann, Andreas Mügge, Stephan Schmidt, Ralf Gold
Endocarditis following ocrelizumab in relapsing-remitting MS. Neurology(R) neuroimmunology & neuroinflammation 7 (3) (2020)
Simon Faissner, Ralf Gold
Progressive multiple sclerosis: latest therapeutic developments and future directions. Therapeutic advances in neurological disorders 12 (2019)
Simon Faissner, Jason R Plemel, Ralf Gold, Voon Wee Yong
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nature reviews. Drug discovery 18 (12) (2019)
Simon Faissner, Ralf Gold
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010. CNS drugs 32 (3) (2019)